CE Education
Welcome to the Managing Myeloma Education Center! Here, in one convenient location, you’ll find an ever-growing compendium of accredited activities that focus on the assessment, diagnosis and treatment of multiple myeloma. Each of these activities highlights clinically relevant, timely and accurate scientific information, designed to support you in your search for additional education and improved patient care.
- The Cutting Edge of Multiple Myeloma: The Evolving Role of CD38-directed Strategies
A series of three accredited podcasts with Dr. Joshua Richter and Dr. Andrew Yee focusing on clinical trials with CD38-targeting agents in newly diagnosed and relapsed/refractory multiple myeloma, as well as future directions and combinations with CD38-targeting agents. - The Role of the ED in Treating Multiple Myeloma in the Era of Novel Immunotherapies
This program focuses on common treatment-related adverse events (TRAEs) associated with novel CAR T-cell and bispecific antibody therapies, including CRS, ICANS, and hemophagocytic lymphohistiocytosis/macrophage-activation syndrome, and management strategies that can be utilized in the emergency setting to re-stabilize patients and support continued care for relapsed/refractory multiple myeloma. - Annual Meeting Highlights
World renowned faculty provide concise summaries and new data from major annual oncology conferences to provide insight on how this new information will impact your daily practice. - Accredited E-Newsletter Series
Text based activities focusing on one specific topic or clinical question relevant to the treatment and care of patients with multiple myeloma. - Practice Essentials
Vignettes that focus on a specific clinical question and/or controversy relative to new advances in the care and treatment of patients with multiple myeloma from both physician and nurse perspectives.
- My Credits
Log in to receive a history of the accredited activities that you have accessed and/or received a certificate of participation.